DH Europe Finance S.a.r.l. EO-Notes 2017(17/27)
- BID
98.418
- ASK
98.483
- 550,000 Nom.550,000 Nom.
- 07/27, 18:02:41 PM
Type of financial instrument
Corporate Bond
Sub-Type
Health Care
Yield
2.97
Yield spread Bundesanleihe
0.2421
Tradable for private investors
No
Minimum amount tradeable unit
100,000.00
Maturity
30/06/2027
Interest Rate
1.20 %
Currency
Euro
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE / YIELD | 98.418 G / 2.97 | 0 Units |
| PRICE DETERMINATION TIME | 07/27/2026 / 06:02:41 PM | |
| DAILY VOLUME (NOMINAL) | 0 | |
| YIELD SPREAD | 0.2421 | |
| FIXINGPRICE | - | |
| DAILY HIGH / LOW | 98.421 | 98.39 |
| PREV. DAY'S PRICE | 98.369 | (07/24) |
| CHANGE DAY BEFORE | +0.05 | 0.05 % |
| 52 WEEK HIGH / LOW | 98.51 (07/06) | 97.784 (03/23) |
Master Data
| WKN | A19KHE |
| ISIN | XS1637162592 |
| SYMBOL | - |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Corporate Bond |
| SUB-TYPE | Health Care |
| ISSUER | DH Europe Finance S.A. |
| S&P RATING | Please log in to view this field |
| (TRADING) SEGMENT / TICKS | -/ - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| INTEREST RATE | 1.20 % |
| INTEREST RUN FROM | 30/06/2017 |
| NEXT INTEREST PAYMENT | 16/06/2027 |
| UNIT INTEREST FROM NOMINAL AMMOUNT | 0.141 % |
| TRADING CURRENCY / NOTATION | Euro/ Percent |
| NOMINAL CURRENCY | Euro |
| SETTLEMENT CURRENCY | Euro |
| QUOTATION | Continuous trading |
| ISSUING VOLUME | 600.00 Mil. |
| MINIMUM AMOUNT TRADEABLE UNIT | 100,000.00 |
| SMALLEST TRADEABLE UNIT | 1,000.00 |
| MATURITY | 30/06/2027 |
| MARKET MAKER | - |
| STEP UP/ DOWN WHEN RATING CHANGES | No |
| STEP UP FIXED AT ISSUE | No |
| STEP DOWN FIXED AT ISSUE | No |
| BOND CALLABLE BY THE ISSUER | No |
| BOND IS SUBORDINATED | No |
Description
Make Whole Call Option. Callable bond.
Tradability Information
Please log in to see the tradability information for this stock.Not registered yet? Create your free account here.
Company profile
Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments: Biotechnology, Life Sciences, and Diagnostics. The Biotechnology segment includes bioprocessing, discovery, and medical businesses and offers a range of tools, consumables, and services. The Life Sciences segment offers a range of instruments and consumables to study the basic building blocks of life, including DNA and RNA. The Diagnostics segment offers clinical instruments, reagents, consumables, software, and services used to diagnose disease and make treatment decisions. The company was founded by Steven M. Rales and Mitchell P. Rales in 1984 and is headquartered in Washington, DC.